Trial to Compare Radiation Fibrosis With Five Versus Three Fractions

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Malignant Neoplasm of Breast Stage I
Interventions
RADIATION

Arm 1 600 cGY x 5 fractions

Patients who are randomized to Arm 1 will receive either 600 cGY x 5 fractions over 5 consecutive days

RADIATION

Arm 2 800 cGY x 3 fractions

Patients who are randomized to Arm 2 will receive 800 cGY x 3 fractions given every other day

Trial Locations (4)

10065

Weill Cornell Medical College, New York

11215

Brooklyn Methodist Hospital - NewYork Presbyterian, New York

11355

New York Presbyterian Hospital - Queens, New York

90033

University of Southern California, Los Angeles

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT02755896 - Trial to Compare Radiation Fibrosis With Five Versus Three Fractions | Biotech Hunter | Biotech Hunter